Patents by Inventor Ruben K. Dagda

Ruben K. Dagda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Disease modifying methods for treating neurodegenerative diseases using nootropic agents
    Patent number: 11612583
    Abstract: The present invention relates to the discovery that Forskolin can be used to treat Parkinson's disease (PD) in subjects in need thereof. In certain embodiments, the invention provides a method of treating PD, wherein a therapeutically effective amount of Forskolin is administered to a subject via intranasal or intrapulmonary routes. In other embodiments, the subject is further administered a therapeutically effective amount of Noopept. In yet other embodiments, the method reverses damage to the subject's brain caused by PD and promotes growth of new neurons.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: March 28, 2023
    Assignee: Nevada Research & Innovation Corporation
    Inventors: Raul Y. Dagda, Ruben K. Dagda
  • Disease Modifying Methods For Treating Neurodegenerative Diseases Using Nootropic Agents
    Publication number: 20210220322
    Abstract: The present invention relates to the discovery that Forskolin can be used to treat Parkinson's disease (PD) in subjects in need thereof. In certain embodiments, the invention provides a method of treating PD, wherein a therapeutically effective amount of Forskolin is administered to a subject via intranasal or intrapulmonary routes. In other embodiments, the subject is further administered a therapeutically effective amount of Noopept. In yet other embodiments, the method reverses damage to the subject's brain caused by PD and promotes growth of new neurons.
    Type: Application
    Filed: June 20, 2019
    Publication date: July 22, 2021
    Inventors: Raul Y. Dagda, Ruben K. Dagda